|
This May, Children’s will launch an online community for our faculty and alumni. Members will be able to:
- search the directory to locate friends and colleagues
- communicate with other members via a secure system
- create professional sub-groups with members in and outside of this Children’s community
- find out about the latest news at Children’s and CME events
To make sure you receive your invitation to this community, please send your email address, name and information about your training at Children's to marketing@childrens.harvard.edu
Children’s Hospital Boston’s new Fetal-Neonatal Neuroimaging and Developmental Science Center will develop hardware and software that will help clinicians diagnose brain injury in fetuses and neonates earlier and more effectively, then develop and implement therapies that will improve long-term health and outcomes.
These technologies will also provide clinical scientists with the ability to test hypotheses and hopefully accelerate the application of neuroimaging advances to routine clinical practice. Ellen Grant, MD, MSc, who has trained in both adult and pediatric neuroradiology, was recruited from Mass. General Hospital for Children to head up the clinic.
Children’s and the Immune Disease Institute (formerly the Center for Blood Research) have entered into an affiliation agreement. This eighth multidisciplinary research program at Children’s will be called the Program in Cellular and Molecular Medicine, and the program’s researchers will pursue four primary areas of research: adhesion molecules and inflammation; autoimmunology and allergy; genetics of immunodeficiency and cancer; and immune defenses against infectious disease, virus and tumors. Fred Alt, PhD, co-chief of the Division of Molecular Medicine, will be the executive director.
Dana-Farber/Children’s Hospital Cancer Care recently started its first treatment protocol that uses radioiodine labeled metaiodobenzylguanidine (I-131 MIBG) for patients with relapsed neuroblastoma. It’s the first therapy of its kind offered in New England.
With a response of almost 40 percent, I-131 MIBG is one of the most effective therapies for children with relapsed neuroblastoma. While it doesn’t cure, I-131 MIBG can allow patients to gain control of their disease and, in combination with other treatments, brings them closer to being cured.
Treatment is delivered by a team of multidisciplinary experts from the hospital, including specialists from Pediatric Oncology, Nursing, Nuclear Medicine, Radiation Safety and
Children’s Division of Sports Medicine has added a new sports psychologist to its team, Sharon Chirban, PhD. Symptoms that warrant a referral are those associated with overtraining, burnout, performance-driven weight loss, female athlete triad symptoms, career transitions, performance anxiety and parent/coach/athlete issues, as well as personality changes after an athletic injury, depression and/or anxiety.
MetroWest Medical Center recently decided to change its pediatric affiliation to Tufts Medical Center, effective in July. This decision follows months of discussion with Childrenís Hospital Boston, in which MetroWest indicated it wanted to greatly expand its pediatric services from its current offerings. Childrenís was unable to staff the services desired by MetroWest and still adequately staff its existing facilities.
Childrenís remains committed to providing a safety net for pediatric care throughout New England. Our specialists continue to staff the neonatal intensive care units, pediatric inpatient units and emergency departments at seven community hospitals, including Beverly Hospital, the Caritas system (St. Elizabethís, Norwood, Holy Family and Good Samaritan), South Shore Hospital and Winchester Hospital.
The hospital also owns and operates three ambulatory facilities, in Waltham, Lexington and Peabody, and a community health center, Martha Eliot Health Center, in Jamaica Plain.
Childrenís network locations: childrenshospital.org/locations
In February, John Meara, MD, DMD, MBA, and others traveled to San Juan, Puerto Rico for the Updates in Pediatric Plastic and Oral Surgery conference at The University of Puerto Rico. Topics highlighted in the Continuing Medical Education conference included cleft lip and palate, plagiocephaly and craniosynostosis, pediatric oral and maxillofacial surgery, midline nasal lesions, cleft orthognathic surgery, breast anomalies, vascular anomalies, pediatric hand surgery and wound management.
Hosted by the Dana-Faber/Childrenís Hospital Cancer Care Program, Seeking Success: Advanced Concepts in Pediatric Oncology will provide a comprehensive review or current treatments, advances, strategies and clinical research in pediatric oncology. The course will be held at Childrenís Hospital Boston at Waltham, and is open to all nursing professionals working with or interested in pediatric oncology nursing and/or those preparing for the CPONÆ certification exam.
More information: Colleen Nixon, BSN, RN, CPONÆ at 617-355-3611 or colleen.nixon@childrens.harvard.edu
On April 18 & 19 seven specialists from Childrenís Division of Sports Medicine will present at the 2nd Annual John Hancock Sports & Fitness Expo at the Hynes Convention Center. Topics include special considerations for child runners, female athlete triad/nutrition in marathon runners, biomechanics related to runnerís injuries, knee pain in the runner, hypo and hyperthermia prevention and treatment, sudden death in the endurance athlete and exertional leg pain in the athlete.
More information about Sports Medicine Specialists: http://children.photobooks.com
On Monday, April 6th the Leon Eisenberg Chair/Professorship in Child Psychiatry will be announced. Academic psychiatrists from around the world will be at the scholarly symposium from 1 p.m. to 4 p.m. in the New Research Building at Harvard Medical School (Blackfan Circle), then a small (invitation only) reception will be held in the Wolbach Building at Childrenís from 5 p.m. to 7 p.m.
|
